17:10 EDT Autolus Therapeutics (AUTL) files to sell 54.58M American depositary shares for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Autolus Therapeutics: Strong Q1 Performance and Strategic Expansion Justify Buy Rating
- Autolus Therapeutics Reports Q1 2025 Financial Results
- Strong Market Entry and Strategic Expansion Drive Buy Rating for Autolus
- Autolus Therapeutics reports Q1 EPS (26c), consensus (25c)
- Autolus Therapeutics’ obecabtagene autoleucel conditionally approved by MHRA